June 3, 2020 / 11:04 PM / a month ago

BRIEF-China Pioneer Pharma Says U.S. FDA Started With Pre-Emergency Use Authorization Process On Coronavirus Test Kit

June 4 (Reuters) - China Pioneer Pharma Holdings Ltd :

* US FDA STARTED WITH PRE-EMERGENCY USE AUTHORIZATION PROCESS ON NOVEL CORONAVIRUS IGG/IGM COMBINED ANTIBODY TEST KIT

* CO ACTS AS EXCLUSIVE AGENT IN US OF VARIOUS NOVEL CORONAVIRUS TEST KITS OF SHENZHEN MICROPROFIT CURRENTLY IN DEVELOPMENT

* CO ACTS AS EXCLUSIVE AGENT IN U.S. FOR 10 YRS FROM 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below